As a governmental research institute, the activity of the IIBR’s biology division is concentrated around applied biomedical research. We focus on the critical needs of healthcare systems, especially during crisis and emergency situations.
By in-depth understanding of the underlining pathology of biological warfare agents, combined with advanced developments of treatment modalities and state-of-the-art antibody engineering, the antibody engineering team develops unique antibody-based solutions for passive-therapy against such pathogens.
Ever since Edward Jenner’s vaccine for smallpox, vaccines have revolutionized preventative medicine. The IIBR is leading an effort in the development of vaccines against select agents. Vaccine development is carried out in three main approaches: Protein-based vaccines, live vaccines and rational design of novel vaccines.
The genomic era paved the way for new avenues in the applicative research of microorganisms. State-of-the-art technologies for sequencing of complete genomes were developed in recent years, together with an arsenal of tools and high-throughput methodologies for analysis and processing of the data generated.
Pre-clinical animal research is key in experimental biology and biomedicine. The design and selection of animal models are form the basis for the validity of scientific experiments, as well as for the careful extrapolation of results to human biology.
We welcome you to contact us for any question or offer for collaborations.
There are some errors in your form.
the mail is recived, thank you